Marimed Inc. SEC filings MRMD

Marimed Inc. has 377 filings in SEC EDGAR's recent list, going back to Jun 9, 2011. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (shareholder vote results, other events). The company's fiscal year ends on December 31.

Form Description Filed Period
DEF 14A Proxy statement Sep 22, 2026 Oct 28, 2026
PRE 14A Preliminary proxy statement Sep 11, 2026 Oct 28, 2026
DEF 14A Proxy statement Apr 23, 2026 Jun 4, 2026
DEF 14A Proxy statement Apr 30, 2025 Jun 12, 2025
DEF 14A Proxy statement Apr 29, 2024 Apr 29, 2024
DEF 14A Proxy statement Apr 27, 2023 Jun 8, 2023
DEF 14A Proxy statement Sep 22, 2022 Sep 22, 2022
DEF 14A Proxy statement Aug 17, 2021 Aug 17, 2021
PRE 14A Preliminary proxy statement Jul 23, 2021 Jul 23, 2021
DEF 14A Proxy statement Aug 26, 2019 Aug 26, 2019
DEF 14C Information statement Feb 6, 2017 Feb 6, 2017
PRE 14C Filing Jan 26, 2017 Jan 26, 2017

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as
MRMD (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Norwood, MA
SEC filer status
, Emerging growth company
SEC CIK
1522767
Former names
WORLDS ONLINE INC. (until May 15, 2017)

Other Medicinal Chemicals & Botanical Products companies

All 43 Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.